Literature DB >> 8110178

Chromosomal localization of human genes for arylamine N-acetyltransferase.

D Hickman1, A Risch, V Buckle, N K Spurr, S J Jeremiah, A McCarthy, E Sim.   

Abstract

Arylamine N-acetyltransferase is encoded at two loci, AAC-1 and AAC-2, on human chromosome 8. The products of the two loci are able to catalyse N-acetylation of arylamine carcinogens, such as benzidine and other xenobiotics. AAC-2 is polymorphic and individuals carrying the slow-acetylator phenotype are more susceptible to benzidine-induced bladder cancer. We have identified yeast artificial chromosome clones encoding AAC-1 and AAC-2 and have used the cloned DNAs as fluorescent probes for in situ hybridization. The hybridization patterns allow assignment of AAC-1 and AAC-2 to chromosome 8p21.3-23.1, a region in which deletions have been associated with bladder cancer [Knowles, Shaw and Proctor (1993) Oncogene 8, 1357-1364].

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8110178      PMCID: PMC1137852          DOI: 10.1042/bj2970441

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver.

Authors:  T Deguchi; M Mashimo; T Suzuki
Journal:  J Biol Chem       Date:  1990-08-05       Impact factor: 5.157

2.  Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver.

Authors:  S Ohsako; T Deguchi
Journal:  J Biol Chem       Date:  1990-03-15       Impact factor: 5.157

3.  A 3.5 genome equivalent multi access YAC library: construction, characterisation, screening and storage.

Authors:  R Anand; J H Riley; R Butler; J C Smith; A F Markham
Journal:  Nucleic Acids Res       Date:  1990-04-25       Impact factor: 16.971

4.  Assignment of the gene determining human carbonic anhydrase, CAI, to chromosome 8.

Authors:  Y H Edwards; J H Barlow; C P Konialis; S Povey; P H Butterworth
Journal:  Ann Hum Genet       Date:  1986-05       Impact factor: 1.670

5.  Drug metabolising N-acetyltransferase activity in human cell lines.

Authors:  E Coroneos; J W Gordon; S L Kelly; P D Wang; E Sim
Journal:  Biochim Biophys Acta       Date:  1991-04-09

6.  Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer.

Authors:  R A Cartwright; R W Glashan; H J Rogers; R A Ahmad; D Barham-Hall; E Higgins; M A Kahn
Journal:  Lancet       Date:  1982-10-16       Impact factor: 79.321

7.  Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression.

Authors:  M Blum; D M Grant; W McBride; M Heim; U A Meyer
Journal:  DNA Cell Biol       Date:  1990-04       Impact factor: 3.311

8.  Arylamine N-acetyltransferase activity in human cultured cell lines.

Authors:  E Coroneos; E Sim
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

9.  The S-acetyl coenzyme A-dependent metabolic activation of the carcinogen N-hydroxy-2-aminofluorene by human liver cytosol and its relationship to the aromatic amine N-acetyltransferase phenotype.

Authors:  T J Flammang; Y Yamazoe; F P Guengerich; F F Kadlubar
Journal:  Carcinogenesis       Date:  1987-12       Impact factor: 4.944

10.  Genetics of somatic mammalian cells: genetic, immunologic, and biochemical analysis with Chinese hamster cell hybrids containing selected human chromosomes.

Authors:  F T Kao; C Jones; T T Puck
Journal:  Proc Natl Acad Sci U S A       Date:  1976-01       Impact factor: 11.205

View more
  25 in total

1.  A simplified assay for the arylamine N-acetyltransferase 2 polymorphism validated by phenotyping with isoniazid.

Authors:  C A Smith; M Wadelius; A C Gough; D J Harrison; C R Wolf; A Rane
Journal:  J Med Genet       Date:  1997-09       Impact factor: 6.318

2.  N-Acetyltransferase polymorphism and human cancer risk.

Authors:  X Yang; T Takeshita; K Morimoto
Journal:  Environ Health Prev Med       Date:  2000-01       Impact factor: 3.674

3.  Arylamine N-acetyltransferase (NAT2) mutations and their allelic linkage in unrelated Caucasian individuals: correlation with phenotypic activity.

Authors:  I Cascorbi; N Drakoulis; J Brockmöller; A Maurer; K Sperling; I Roots
Journal:  Am J Hum Genet       Date:  1995-09       Impact factor: 11.025

4.  Arylamine N-acetyltransferase in Balb/c mice: identification of a novel mouse isoenzyme by cloning and expression in vitro.

Authors:  S L Kelly; E Sim
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

5.  Haplotype of N-acetyltransferase 1 and 2 and risk of pancreatic cancer.

Authors:  Li Jiao; Mark A Doll; David W Hein; Melissa L Bondy; Manal M Hassan; James E Hixson; James L Abbruzzese; Donghui Li
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-11       Impact factor: 4.254

6.  Mycobacterium tuberculosis Arylamine N-Acetyltransferase Acetylates and Thus Inactivates para-Aminosalicylic Acid.

Authors:  Xude Wang; Shanshan Yang; Jing Gu; Jiaoyu Deng
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

7.  Polymorphism of N-acetyltransferase 1 and correlation between genotype and phenotype in a Thai population.

Authors:  Veerapol Kukongviriyapan; Auemduan Prawan; Benjamart Warasiha; Wichittra Tassaneyakul; Jareerat Aiemsa-ard
Journal:  Eur J Clin Pharmacol       Date:  2003-07-19       Impact factor: 2.953

8.  Identification of a minimal promoter sequence for the human N-acetyltransferase Type I gene that binds AP-1 (activator protein 1) and YY-1 (Yin and Yang 1).

Authors:  Neville J Butcher; Ajanthy Arulpragasam; Catherine Pope; Rodney F Minchin
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

Review 9.  Phase I and II enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis.

Authors:  L M Bull; D L White; M Bray; Z Nurgalieva; H B El-Serag
Journal:  Dis Esophagus       Date:  2009-02-13       Impact factor: 3.429

10.  Genetic polymorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer.

Authors:  M V González; V Alvarez; M F Pello; M J Menéndez; C Suárez; E Coto
Journal:  J Clin Pathol       Date:  1998-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.